✅ Suggested content. Review the technical data and compliance, adjust whatever you need and delete this line before publishing.
Tesamorelin is a synthetic analog of GHRH (growth hormone-releasing factor), a hormone that stimulates the secretion of growth hormone from the pituitary. It is studied in endocrine and metabolic research. NeoPeptidos offers it with ≥99% HPLC purity, for research use.
Technical profile
| Product | Tesamorelin |
|---|---|
| CAS | 218949-48-5 |
| Molecular formula | C₂₂₁H₃₆₆N₇₂O₆₇S |
| Molecular weight | 5135.90 Da |
| Sequence | trans-3-hexenoyl-GHRH(1-44)-NH₂ (44 aa) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is Tesamorelin?
Unlike direct growth hormone, Tesamorelin acts one step earlier: it mimics GHRH to stimulate the release of the body's own growth hormone. That is why it is classified as a GHRH analog, and its structure is stabilized to resist degradation.
Research context
The literature on Tesamorelin has focused on the GHRH–GH axis and on research into visceral fat metabolism in models and clinical studies.
The NeoPeptidos product is research-grade material; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on June 9, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).